Skip to main content

ADVERTISEMENT

Peripheral arterial disease

Commentary
11/16/2022

Monica Majumdar, MD, MPH; Anahita Dua, MD, MS, MBA, FACS

 

Division of Vascular and Endovascular Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Monica Majumdar, MD, MPH; Anahita Dua...
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective differences in responsiveness to antiplatelet medications between the sexes to explain why women with PAD have fewer risk factors yet higher rates of nonhealing and amputation?
Can we delineate objective...
11/16/2022
Vascular Disease Management
Emerging Insights On PAD, CLTI And The Gaps In Limb Salvage During The COVID-19 Pandemic
Diabetes Watch
04/09/2021
By Priyanka Singh, MD and Anuj Shah, MD, FACC, FSCAI
By Priyanka Singh, MD and Anuj Shah, ...
Best medical treatment for peripheral arterial disease (PAD) includes managing hypertension, diabetes, dyslipidemia and associated risk factors like smoking.
Best medical treatment for peripheral arterial disease (PAD) includes managing hypertension, diabetes, dyslipidemia and associated risk factors like smoking.
Best medical treatment for...
04/09/2021
Podiatry Today
A Closer Look At The Complexity Of PAD Screening In Patients With Diabetes
Diabetes Watch
01/27/2021
By Christine Miller, DPM, PhD, FACCWS
By Christine Miller, DPM, PhD, FACCWS...
Peripheral arterial disease (PAD) is a condition affecting approximately 8.5 million Americans over the age of 40 and more than 20 million people worldwide.1 Thiruvoipati has defined PAD as atherosclerotic disease of the lower extremity with...
Peripheral arterial disease (PAD) is a condition affecting approximately 8.5 million Americans over the age of 40 and more than 20 million people worldwide.1 Thiruvoipati has defined PAD as atherosclerotic disease of the lower extremity with...
Peripheral arterial disease...
01/27/2021
Podiatry Today
Blog
01/15/2021
David G. Armstrong DPM MD PhD
How reliable are our screening tools for peripheral arterial disease (PAD)? A recently published meta-analysis suggests that while our current diagnostic testing measures are promising, one should be wary of relying upon any one tool in...
How reliable are our screening tools for peripheral arterial disease (PAD)? A recently published meta-analysis suggests that while our current diagnostic testing measures are promising, one should be wary of relying upon any one tool in...
How reliable are our screening...
01/15/2021
Podiatry Today
Blog
11/20/2020
Mark Hinkes DPM FACFAS FAPWCA DABFAS
It is estimated that non-healing wounds affect approximately seven to eight million people in the U.S. while an estimated nine million people have peripheral arterial disease (PAD).1 Peripheral arterial disease is often an unrecognized cause...
It is estimated that non-healing wounds affect approximately seven to eight million people in the U.S. while an estimated nine million people have peripheral arterial disease (PAD).1 Peripheral arterial disease is often an unrecognized cause...
It is estimated that non-healing...
11/20/2020
Podiatry Today
Evidence Corner
04/03/2020
Laura Bolton
Summarized herein, 2 Cochrane reviews clarify the quality and quantity of evidence of the effects on CLI-related outcomes comparing percutaneous transluminal angioplasty, a procedure for opening infrapopliteal arteries by inflating an...
Summarized herein, 2 Cochrane reviews clarify the quality and quantity of evidence of the effects on CLI-related outcomes comparing percutaneous transluminal angioplasty, a procedure for opening infrapopliteal arteries by inflating an...
Summarized herein, 2 Cochrane...
04/03/2020
Wounds
First large randomized trial compares open bypass surgery to endovascular treatment of femoropopliteal lesions
Symposia
02/26/2020
Dr. Marc Bosiers, principal investigator, reports on 2-year results of the ZILVERPASS trial. Watch the video.
Dr. Marc Bosiers, principal investigator, reports on 2-year results of the ZILVERPASS trial. Watch the video.
Dr. Marc Bosiers, principal...
02/26/2020
Vascular Disease Management
Blog
12/05/2019
David G. Armstrong DPM MD PhD
In a study soon to be published in Microvascular Research, Wu and colleagues took a closer look at the effect of walking speed and duration on the blood flow to plantar skin. Studying non-diabetics in this cohort to establish a “normal...
In a study soon to be published in Microvascular Research, Wu and colleagues took a closer look at the effect of walking speed and duration on the blood flow to plantar skin. Studying non-diabetics in this cohort to establish a “normal...
In a study soon to be published...
12/05/2019
Podiatry Today
Original Research
11/01/2019
Iram Naz
Elliot T. Walters
David E. Janhofer
Morgan M. Penzler
Eshetu A. Tefera
Karen K. Evans
John S. Steinberg
Christopher E. Attinger
Cameron M. Akbari
Paul J. Kim
In this study, the authors examine factors predictive of STSG healing in patients with PAD following vascular intervention, including the effect of non-inline flow via arterial-arterial and non-arterial collateralization.
In this study, the authors examine factors predictive of STSG healing in patients with PAD following vascular intervention, including the effect of non-inline flow via arterial-arterial and non-arterial collateralization.
In this study, the authors...
11/01/2019
Wounds
Original Research
10/01/2018
Charles A. Andersen
Mario Ponticello
Nicole Byerley
Valerie Marmolejo
10/01/2018
Wounds